BMEA — Biomea Fusion Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Biomea Fusion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.6 | -81.8 | -117 | -138 | -61.8 |
| Depreciation | |||||
| Non-Cash Items | 7.45 | 11.1 | 16.8 | 21.9 | -6.29 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.57 | 7.67 | 2.33 | -5.15 | -3.7 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -35.4 | -62.4 | -96.6 | -120 | -70.4 |
| Capital Expenditures | -3.17 | -1.03 | -3.37 | -0.362 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.2 | 28.4 | 1.15 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -33.4 | 27.3 | -2.22 | -0.362 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 153 | 1.24 | 164 | 1.67 | 67.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 84.4 | -33.8 | 65 | -119 | -2.47 |